T Xpan™ Cell Activator (CD3/CD28/CD2)
| Cat. No. | TM139 |
| Name | T Xpan™ Cell Activator (CD3/CD28/CD2) |
| Description |
Triple CD3/CD28/CD2 co-stimulation for robust primary T cell activation and expansion within 24–48 hours.
T Xpan™ Cell Activator (CD3/CD28/CD2) is a high-performance reagent for robust activation and expansion of primary human T cells via simultaneous CD3, CD28, and CD2 stimulation. By mimicking antigen-presenting cell co-stimulation, TM139 promotes rapid T cell clustering, activation, proliferation, and survival while maintaining high viability. Distinct activation morphology is typically observed within 24–48 hours post-stimulation. TM139 is optimized for T cell expansion workflows, CAR-T research and development, immunotherapy studies, cytokine production assays, and T cell functional analyses.
Key Features: |
| Unit | 500 µl |
| Usage |
Add T Xpan™ Cell Activator (CD3/CD28/CD2) at 2 µl per 1 × 10⁶ cells under standard activation conditions. Primary human T cells are then incubated for 24-48 hours, during which clear T cell clustering and activation morphology is observed, progressing from resting single cells to activated aggregates and clusters. Optimize conditions based on donor variability and downstream applications.
For more details, please refer to the Datasheet. |
| Sterility | Sterile |
| Application |
|
| QC |
For information on validation, see Technical Sheet under the Documents tab. |
| Storage Condition | Store at 2-8°C |
| Material Citation | If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. TM139 |